BTC $71,807
2026 Bull Run Is Building Start trading with 5% OFF all fees
Sign Up Now
BTC $71,807
Bull Run 2026 | 5% Off Fees Open your Binance account today
Sign Up

Goldman Sachs: Nvidia Buy, $250 Target, 51% Upside

Goldman Sachs sees 51% Nvidia upside, cites healthcare AI and biotech partnerships as key growth drivers.

  • Goldman Sachs reaffirmed its ‘Buy’ rating for NVIDIA, setting a $250 price target that suggests a 51% upside from recent levels.
  • The firm’s analysts identified healthcare and life sciences as key growth drivers, with strategic biotech partnerships allowing Nvidia to refine its AI models in real-world labs.
  • Nvidia’s collaboration with Recursion Pharmaceuticals demonstrates tangible AI efficiencies, accelerating drug discovery timelines.
  • Despite the positive analyst outlook, retail investor sentiment on platforms like Stocktwits remained bearish as of March 31, 2026.

On March 31, 2026, Goldman Sachs maintained its bullish stance on Nvidia Corp., according to a CNBC report. The firm reiterated a ‘Buy’ rating with a $250 price target, signaling strong conviction in the chipmaker’s future amid rising AI demand. This target implied a potential 51% gain from the stock’s closing price earlier that week.

- Advertisement -

Analyst Salveen Richter highlighted Nvidia’s deepening collaborations with biotech firms as a major catalyst. These partnerships enable the testing and validation of AI models in laboratory environments, expanding applications into digital health and manufacturing. Consequently, the expanding use cases in drug development and clinical research may unlock meaningful upside for the semiconductor leader.

The strategic investment in Recursion Pharmaceuticals Inc. is already yielding results. Recursion reported that its AI-powered platform drastically reduces the number of compounds needing synthesis and shortens timelines to human testing. Meanwhile, machine learning is also improving clinical trial design by enhancing patient group identification and data analysis.

Nvidia’s stock traded over 3% higher following the analyst note. However, retail sentiment on Stocktwits remained in ‘bearish’ territory with low message volume. This contrasted with the professional analyst optimism, as Nvidia’s shares had declined over 8% year-to-date by that point.

✅ Follow BITNEWSBOT on Telegram, Facebook, LinkedIn, X.com, and Google News for instant updates.

- Advertisement -

Previous Articles:

- Advertisement -
Ad
Altseason Is Loading. Don't watch from the sidelines.
SOL $90.51
DOGE $0.0963
LINK $9.02
SUI $1.00
5% off fees when you sign up
Start Trading
Ad
Pay Less on Every Trade. For Life.
$10K/mo volume Save $60/yr
$50K/mo volume Save $300/yr
$100K/mo volume Save $600/yr
5% off all trading fees when you sign up
Claim Your Discount

Latest News

ImmunityBio founder touts sepsis trials, NantX after Binance theft

Patrick Soon-Shiong renewed his “NantX coming soon” teaser after a $6.3 billion Binance theft,...

Crypto.com Shuts Hong Kong App, Eyes Institutional Exchange

crypto.com will shut down its consumer app in Hong Kong on Feb. 1, 2027,...

Kim Yo Jong denies North Korea behind Binance hack, hints US

Kim Yo Jong denied North Korea's involvement in the $6.3 billion Binance hack and...

Strive buys 124 BTC, fourth among public companies

Strive acquired 124 Bitcoin for roughly $10 million between Oct. 24 and Oct. 30,...

Claude finds 9.8 zero-click Linux root bug

Claude discovered a zero-click Linux vulnerability (CVE-2026-98432) rated 9.8 out of 10, described as...

Must Read

Best Crypto Audiobooks of 2026: The Ultimate Listen & Learn Guide

You can't read Bitcoin charts while driving 70 mph on the highway. You can't study Ethereum whitepapers during your morning run. But you can...
Ad
Altseason Is Loading. These 4 coins are trending right now.
SOL $92.12
DOGE $0.0950
LINK $9.02
SUI $1.02
5% off spot fees when you sign up
Start Trading